These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

735 related items for PubMed ID: 14623544

  • 1. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients.
    Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T.
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544
    [Abstract] [Full Text] [Related]

  • 2. [Steroid sulfatase inhibitor].
    Nakata T, Ishida H, Shiotsu Y.
    Nihon Rinsho; 2010 Jun; 68(6):1073-8. PubMed ID: 20535958
    [Abstract] [Full Text] [Related]

  • 3. New development in intracrinology of breast carcinoma.
    Sasano H, Suzuki T, Nakata T, Moriya T.
    Breast Cancer; 2006 Jun; 13(2):129-36. PubMed ID: 16755106
    [Abstract] [Full Text] [Related]

  • 4. A new therapeutic strategy against hormone-dependent breast cancer: the preclinical development of a dual aromatase and sulfatase inhibitor.
    Foster PA, Chander SK, Newman SP, Woo LW, Sutcliffe OB, Bubert C, Zhou D, Chen S, Potter BV, Reed MJ, Purohit A.
    Clin Cancer Res; 2008 Oct 15; 14(20):6469-77. PubMed ID: 18927286
    [Abstract] [Full Text] [Related]

  • 5. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J, Chetrite G, Meschi S, Pasqualini JR.
    J Steroid Biochem Mol Biol; 2005 Jan 15; 93(1):1-13. PubMed ID: 15748827
    [Abstract] [Full Text] [Related]

  • 6. Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators.
    Geisler J.
    J Steroid Biochem Mol Biol; 2003 Sep 15; 86(3-5):245-53. PubMed ID: 14623518
    [Abstract] [Full Text] [Related]

  • 7. Effect of tamoxifen or anastrozole on steroid sulfatase activity and serum androgen concentrations in postmenopausal women with breast cancer.
    Stanway SJ, Palmieri C, Stanczyk FZ, Folkerd EJ, Dowsett M, Ward R, Coombes RC, Reed MJ, Purohit A.
    Anticancer Res; 2011 Apr 15; 31(4):1367-72. PubMed ID: 21508387
    [Abstract] [Full Text] [Related]

  • 8. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR, Chetrite GS.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):221-36. PubMed ID: 15860265
    [Abstract] [Full Text] [Related]

  • 9. Steroid sulfatase: a new target for the endocrine therapy of breast cancer.
    Stanway SJ, Delavault P, Purohit A, Woo LW, Thurieau C, Potter BV, Reed MJ.
    Oncologist; 2007 Apr 15; 12(4):370-4. PubMed ID: 17470679
    [Abstract] [Full Text] [Related]

  • 10. Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.
    Dias NJ, Selcer KW.
    Steroids; 2014 Oct 15; 88():77-82. PubMed ID: 25042472
    [Abstract] [Full Text] [Related]

  • 11. A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
    Rasmussen LM, Zaveri NT, Stenvang J, Peters RH, Lykkesfeldt AE.
    Breast Cancer Res Treat; 2007 Dec 15; 106(2):191-203. PubMed ID: 17268816
    [Abstract] [Full Text] [Related]

  • 12. Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers.
    Purohit A, Foster PA.
    J Endocrinol; 2012 Feb 15; 212(2):99-110. PubMed ID: 21859802
    [Abstract] [Full Text] [Related]

  • 13. Steroid sulfatase inhibitors: promising new tools for breast cancer therapy?
    Geisler J, Sasano H, Chen S, Purohit A.
    J Steroid Biochem Mol Biol; 2011 May 15; 125(1-2):39-45. PubMed ID: 21356310
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of hormone therapy on E1S-sulfatase activity in non-malignant and cancerous breast cells in vitro.
    Stute P, Götte M, Kiesel L.
    Breast Cancer Res Treat; 2008 Apr 15; 108(3):363-74. PubMed ID: 17546497
    [Abstract] [Full Text] [Related]

  • 15. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
    Fournier MA, Poirier D.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):142-5. PubMed ID: 18817841
    [Abstract] [Full Text] [Related]

  • 16. Anti-tumor effect of Shu-Gan-Liang-Xue decoction in breast cancer is related to the inhibition of aromatase and steroid sulfatase expression.
    Zhou N, Han SY, Zhou F, Li PP.
    J Ethnopharmacol; 2014 Jul 03; 154(3):687-95. PubMed ID: 24809288
    [Abstract] [Full Text] [Related]

  • 17. Steroid metabolism in breast cancer.
    Foster PA.
    Minerva Endocrinol; 2008 Mar 03; 33(1):27-37. PubMed ID: 18277377
    [Abstract] [Full Text] [Related]

  • 18. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
    Ishida H, Nakata T, Suzuki M, Shiotsu Y, Tanaka H, Sato N, Terasaki Y, Takebayashi M, Anazawa H, Murakata C, Li PK, Kuwabara T, Akinaga S.
    Breast Cancer Res Treat; 2007 Dec 03; 106(2):215-27. PubMed ID: 17268815
    [Abstract] [Full Text] [Related]

  • 19. Steroid sulphatase inhibitors for breast cancer therapy.
    Purohit A, Woo LW, Chander SK, Newman SP, Ireson C, Ho Y, Grasso A, Leese MP, Potter BV, Reed MJ.
    J Steroid Biochem Mol Biol; 2003 Sep 03; 86(3-5):423-32. PubMed ID: 14623540
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW, Hegde PV, Li PK.
    Cancer Res; 1997 Feb 15; 57(4):702-7. PubMed ID: 9044848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.